In the real-world, Pluvicto™ showed 13.5 months median PFS in chemo-naïve patients with PSMA-positive mCRPC; Real‑world evidence showed Pluvicto achieved longer PFS when init ...
CHOP receives $10 million grant for project that uses clinical data analysis to combat rare diseases
The Center for Data Driven Discovery in Biomedicine at the Children's Hospital of Philadelphia received a $10 million federal grant for the development of Real-time Analysis and Discovery in ...
Cancer patients' messages about radiology/pathology reports: Insights for AI. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component ...
CRF acquired Spark Therapeutics, Inc.’s SPK-7001 CHM gene therapy assets and is analyzing long-term data to identify ...
In the last decade, the volume of clinical trial data has surged, presenting unprecedented challenges for sponsors and contract research organizations (CROs). The task of collecting, cleaning, ...
Palliative Radiotherapy Near the End of Life: An Analysis of Factors Influencing the Administration of Radiotherapy in Advanced Tumor Disease Clinical trial activity in radiation oncology has ...
Completed clinical results with ratutrelvir confirm a differentiated profile versus PAXLOVID® with fewer adverse events and no viral rebounds with equivalent time to sustained symptom resolution; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results